ClinConnect ClinConnect Logo
Search / Trial NCT06383988

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 22, 2024

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers ...

Gender

ALL

Eligibility criteria

  • Patient Inclusion Criteria:
  • Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
  • Must have a current diagnosis of new or recurrent stage II-IV lung cancer
  • Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
  • Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
  • Must s elf-report receiving unpaid care from a caregiver who meets the study caregiver criteria and who is willing to participate
  • Caregiver Inclusion Criteria:
  • Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
  • Must self-report providing the majority of the unpaid care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
  • Must have access to the internet at home or be willing to use CONNECT in the clinic
  • Must have access to telephone to complete sessions with the central caregiver navigator
  • Patient Exclusion Criteria:
  • Post-treatment survivors at the time of study enrollment
  • Enrolled in hospice care
  • Unable to read and English and not willing to have someone read surveys for them
  • Caregiver Exclusion Criteria:
  • Self-report currently receiving cancer treatment
  • Unable to read and communicate in English, as the CONNECT intervention is currently only available in English

About Wake Forest University Health Sciences

Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.

Locations

Bronx, New York, United States

Memphis, Tennessee, United States

Milwaukee, Wisconsin, United States

Augusta, Georgia, United States

Wilkes Barre, Pennsylvania, United States

Spartanburg, South Carolina, United States

Scranton, Pennsylvania, United States

Honolulu, Hawaii, United States

Springfield, Missouri, United States

Appleton, Wisconsin, United States

Greenville, South Carolina, United States

Greenville, South Carolina, United States

Green Bay, Wisconsin, United States

Kenosha, Wisconsin, United States

Denver, Colorado, United States

Rehoboth Beach, Delaware, United States

Columbus, Mississippi, United States

Grenada, Mississippi, United States

New Albany, Mississippi, United States

Oxford, Mississippi, United States

Southhaven, Mississippi, United States

Gaffney, South Carolina, United States

Greer, South Carolina, United States

Union, South Carolina, United States

Collierville, Tennessee, United States

Neenah, Wisconsin, United States

'Aiea, Hawaii, United States

Osage Beach, Missouri, United States

Winston Salem, North Carolina, United States

Millville, Delaware, United States

Lafayette, Colorado, United States

Lone Tree, Colorado, United States

Patients applied

0 patients applied

Trial Officials

Kathryn Weaver, PhD

Study Chair

Wake Forest University Health Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported